Wang Dong, Wu Zhihong, Zhou Jun, Zhang Xiaotian
Department of Cardiology, Wuhan No.1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Rheumatology, Wuhan No.1 Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Endocrine. 2020 Aug;69(2):278-285. doi: 10.1007/s12020-020-02280-x. Epub 2020 Apr 17.
The relationship between the rs9939609 allele of fat mass and obesity-associated (FTO) gene and metabolic syndrome (MS) susceptibility has been evaluated by many studies, however, the results still remained controversial in the Chinese population. In order to provide more accurate results, we performed this meta-analysis.
We searched PubMed, and Wanfang Med Online in both English and Chinese, and eight eligible studies comprising of 5345 cases and 9523 controls were eventually selected into our meta-analysis. The meta-analysis was performed using the STATA 12.0 software.
In pooled analysis, the FTO gene rs9939609 polymorphism significantly increased MS susceptibility under per-allele comparisons (A vs. T) (OR 1.21, 95% CI 1.10-1.35, P < 0.001) and in dominant model (OR 1.35, 95% CI 1.13-1.62, P < 0.001). Subgroup analyses under per-allele comparisons (A vs. T) indicated that the elevated risk was observed in adults (OR 1.26, 95% CI 1.08-1.47, P = 0.003) but not in children and adolescents (OR 1.14, 95% CI 0.95-1.36, P = 0.17), and that the risk for increasing MS was only identified in IDF groups (OR 1.22, 95% CI 1.03-1.43, P = 0.018) but not in NCEP ATP III groups (OR 1.14, 95% CI 0.95-1.36, P = 0.17); in both population-based (PB) and hospital-based (HB) groups, A alleles of rs9939609 appeared to be linked to increased MS susceptibilities (HB group: OR 1.51, 95% CI 1.10-2.08, P = 0.01; PB group: OR 1.19, 95% CI 1.09-1.30, P < 0.001). No significant association was established in dominant model subgroup analyses except PB group (OR 1.29, 95% CI 1.05-1.53, P < 0.001).
Our results suggested that the FTO gene rs9939609 polymorphism significantly increased MS susceptibility in Chinese. Our results should be verified by well-designed studies with larger sample size.
脂肪量和肥胖相关(FTO)基因的rs9939609等位基因与代谢综合征(MS)易感性之间的关系已被多项研究评估,然而,在中国人群中结果仍存在争议。为了提供更准确的结果,我们进行了这项荟萃分析。
我们检索了英文和中文的PubMed及万方医学在线,最终纳入8项符合条件的研究,共5345例病例和9523例对照进行荟萃分析。使用STATA 12.0软件进行荟萃分析。
在汇总分析中,FTO基因rs9939609多态性在等位基因比较(A对T)(比值比1.21,95%可信区间1.10 - 1.35,P < 0.001)和显性模型(比值比1.35,95%可信区间1.13 - 1.62,P < 0.001)下显著增加MS易感性。等位基因比较(A对T)的亚组分析表明,成年人中观察到风险升高(比值比1.26,95%可信区间1.08 - 1.47,P = 0.003),但儿童和青少年中未观察到(比值比1.14,95%可信区间0.95 - 1.36,P = 0.17),且仅在国际糖尿病联盟(IDF)组中发现MS增加风险(比值比1.22,95%可信区间1.03 - 1.43,P = 0.018),而在美国国家胆固醇教育计划成人治疗组第三次报告(NCEP ATP III)组中未发现(比值比1.14,95%可信区间0.95 - 1.36,P = 0.17);在基于人群(PB)和基于医院(HB)的组中,rs9939609的A等位基因似乎与MS易感性增加有关(HB组:比值比1.51,95%可信区间1.10 - 2.08,P = 0.01;PB组:比值比1.19,95%可信区间1.09 - 1.30,P < 0.001)。除PB组外,显性模型亚组分析未发现显著关联(比值比1.29,95%可信区间1.05 - 1.53,P < 0.001)。
我们的结果表明,FTO基因rs9939609多态性在中国人群中显著增加MS易感性。我们的结果应由设计良好、样本量更大的研究进行验证。